Bristol-Myers Squibb

Big Pharma to benefit from growth in diabetes: S&P
Marketwatch
Fri, 10/5/12 - 11:18 am
diabetes
Big Pharma
Eli Lilly
Merck
Bristol-Myers Squibb
3 Things to Watch With Celldex Therapeutics
Motley Fool
Thu, 10/4/12 - 10:52 am
Celldex
rindopepimut
CDX-011
Pfizer
Bristol-Myers Squibb
Amgen
Seattle Genetics
Sanofi Defends Lyxumia Under Scrutiny at Diabetes Meeting
Bloomberg
Thu, 10/4/12 - 10:50 am
Sanofi
Lyxumia
diabetes
Bristol-Myers Squibb
Celgene's Pipeline Offers Catalysts Into 2013
Seeking Alpha
Thu, 10/4/12 - 10:43 am
Celgene
JNJ
Bristol-Myers Squibb
Roche
ONYX Pharmaceuticals
Abraxane
Eli Lilly
Bristol-Myers, Sanofi revamp Plavix sales alliance
Yahoo/AP
Wed, 10/3/12 - 12:39 pm
Plavix
Bristol-Myers Squibb
Sanofi
Bristol-Myers Squibb - Between Patent Deadlines And Revenue Shifts
Seeking Alpha
Wed, 10/3/12 - 10:50 am
patents
Bristol-Myers Squibb
Amylin
AstraZeneca
Novo Nordisk
Eli Lilly
Merck
J&J Experimental Diabetes Drug Helps High-Risk Patients
Bloomberg
Tue, 10/2/12 - 10:05 am
diabetes
JNJ
canagliflozin
Dapagliflozin
Bristol-Myers Squibb
AstraZeneca
ARIAD Pharmaceuticals: Ponatinib Approval Anticipated In Second-Line CML
Seeking Alpha
Mon, 10/1/12 - 11:27 am
Ponatinib
CML
Ariad Pharmaceuticals
Pfizer
Bristol-Myers Squibb
Novartis
New Four- and Five-Year Survival Data for YERVOY® (ipilimumab) in Treatment-Naïve and Previously-Treated Metastatic Melanoma Presented at the ESMO 2012 Congress (European Society for Medical Oncology)
Yahoo/BusinessWire
Sat, 09/29/12 - 12:24 pm
Yervoy
melanoma
Bristol-Myers Squibb
Trading Merck Ahead of the Patent Cliff
Motley Fool
Fri, 09/28/12 - 11:40 am
Merck
patent cliff
Pfizer
Lipitor
Singulair
Plavix
Bristol-Myers Squibb
Roche should pick up AbbVie or BMS, analyst thinks
Fierce Pharma
Fri, 09/28/12 - 10:49 am
AbbVie
Roche
Bristol-Myers Squibb
M&A
FDA to decide by March on Pfizer/Bristol blood thinner
Reuters
Wed, 09/26/12 - 10:04 pm
FDA
Pfizer
Bristol-Myers Squibb
bloodthinners
Eliquis
Bristol-Myers Squibb And The Promise Of Cancer Immunotherapy
Seeking Alpha
Tue, 09/25/12 - 11:53 am
Bristol-Myers Squibb
melanoma
Yervoy
How Many Pharmas Does It Take to Accelerate Drug Development?
Motley Fool
Tue, 09/25/12 - 10:04 am
drug development
Abbott Labs
AstraZeneca
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
GSK
JNJ
Pfizer
Roche
Sanofi
TransCelerate BioPharma
Pfizer: Here’s How We are Combating Generic Drugs
Wall St. Cheat Sheet
Mon, 09/24/12 - 12:14 pm
generics
Pfizer
Eliquis
Bristol-Myers Squibb
3 Pharmaceuticals Pursuing Non-Surgical Approaches To Combating Cancer
Seeking Alpha
Mon, 09/24/12 - 11:18 am
OncoSec
Celsion
AngioDynamics
Bristol-Myers Squibb
cancer
European Medicines Agency has recommendations for Novartis, Pfizer, Bristol-Myers Squibb and others
Pharma Times, UK
Mon, 09/24/12 - 11:07 am
Pfizer
Bristol-Myers Squibb
Eliquis
stroke
IBS
Almirall
Novartis
Europe
Bristol-Myers Squibb Company (BMY): Today's Featured Drugs Winner
The Street
Sat, 09/22/12 - 03:34 pm
Bristol-Myers Squibb
Report: Roche's Zelboraf, BMS' Yervoy control their segment
Fierce Pharma
Fri, 09/21/12 - 01:13 pm
Roche
Zelboraf
Bristol-Myers Squibb
Yervoy
melanoma
Apixaban (Eliquis) For Atrial Fibrillation Gets Positive European Recommendation
Forbes
Fri, 09/21/12 - 11:52 am
Apizaban
Eliquis
atrial fibrillation
Europe
Pfizer
Bristol-Myers Squibb

Pages